APA (7th ed.) Citation

Tseng, P., Zeng, B., Hsu, C., Hung, C., Carvalho, A. F., Stubbs, B., . . . Liang, C. (2025). The pharmacodynamics-based prophylactic benefits of GLP-1 receptor agonists and SGLT2 inhibitors on neurodegenerative diseases: Evidence from a network meta-analysis. BMC medicine, 23(1), 197-19. https://doi.org/10.1186/s12916-025-04018-w

Chicago Style (17th ed.) Citation

Tseng, Ping-Tao, et al. "The Pharmacodynamics-based Prophylactic Benefits of GLP-1 Receptor Agonists and SGLT2 Inhibitors on Neurodegenerative Diseases: Evidence from a Network Meta-analysis." BMC Medicine 23, no. 1 (2025): 197-19. https://doi.org/10.1186/s12916-025-04018-w.

MLA (9th ed.) Citation

Tseng, Ping-Tao, et al. "The Pharmacodynamics-based Prophylactic Benefits of GLP-1 Receptor Agonists and SGLT2 Inhibitors on Neurodegenerative Diseases: Evidence from a Network Meta-analysis." BMC Medicine, vol. 23, no. 1, 2025, pp. 197-19, https://doi.org/10.1186/s12916-025-04018-w.